【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 18
1.2 List of Figures 26
2 Introduction 31
2.1 Catalyst 32
3 Clinical Outcomes 34
3.1 Disease Management 34
3.1.1 Intracranial Aneurysms 34
3.1.2 Intracranial Arteriovenous Malformations 35
3.1.3 Dural Arteriovenous Fistulas 36
3.1.4 Intracranial and Extracranial Atherosclerotic Disease 36
3.1.5 Stroke 37
3.2 Treatment Modalities 38
3.2.1 Overview 38
3.2.2 Medical/Chemical Therapy 39
3.2.3 Surgical Therapy 40
3.2.4 Endovascular Therapy 42
4 Industry Overview 53
4.1 Overview 53
4.2 Procedure Trends 53
4.2.1 Intracranial Aneurysms 53
4.2.2 Intracranial Arteriovenous Malformations 59
4.2.3 Atherosclerotic Disease 60
4.2.4 Acute Ischemic Stroke 65
4.3 Market Access 68
4.3.1 Regulatory Process 70
4.3.2 Physician Perception and Decision Making Process 76
4.3.3 Variations in Clinical Practice 82
4.3.4 Lack of Clinical Data 82
4.3.5 Regional-Level Control 83
4.3.6 Cost-Considerations 84
4.3.7 Reimbursement Trends 89
4.4 Regulatory Issues/Recalls 98
4.4.1 Regulatory Issues 98
4.4.2 Product Recalls 99
4.5 Mergers and Acquisitions/Key Partnerships 99
4.5.1 Covidien and Nfocus Neuromedical 99
4.5.2 Stryker Corporation and Surpass Medical 100
4.5.3 Covidien and MindFrame 100
4.5.4 Covidien and Reverse Medical Corporation 100
4.5.5 Stryker Corporation and Boston Scientific Neurovascular 101
4.5.6 Stryker Corporation and Concentric Medical 101
4.5.7 Covidien and ev3 102
4.5.8 Medtronic and Invatec 102
4.5.9 Johnson & Johnson and Micrus Endovascular 102
4.5.10 ev3 and Chestnut Medical Technologies 103
4.5.11 Boston Scientific Corporation and Guidant Corporation 103
4.6 Economic Impact 104
4.6.1 Economic Impact of Intracranial Aneurysms and Arteriovenous Malformations 104
4.6.2 Economic Impact of Stroke 105
4.6.3 Treatment Costs of Cerebrovascular Disease 106
5 Unmet Needs 110
5.1 Overview 110
5.2 Need for Practice, Performance, and Physician Training Guidelines 110
5.3 Lack of Clinical Data 111
5.4 Improve Management of Acute Ischemic Stroke 112
5.5 Address Complications of Surgical Therapy 114
5.6 Addressing the Challenges of Surgical Clipping 114
5.7 Lack of Optimal Treatment Strategy for Unruptured Intracranial Aneurysms 115
5.8 Need for Effective Therapies for Complex Aneurysm Morphologies and Sizes 116
5.9 Difficulty in Treating Intracranial Arteriovenous Malformations 117
5.10 Eliminating Mechanisms of Failure with Balloon Angioplasty 118
5.11 Addressing Challenges of Neurovascular Stenting 119
5.11.1 Risk of Post-Procedural Complications 119
5.11.2 In-Stent Restenosis 120
5.11.3 Stent Navigation 120
5.12 Complications of Dual Antiplatelet Therapy 120
5.13 Need to Improve Medical Therapy 121
5.14 Improve Ease of Access 122
6 Market Opportunity Analysis 123
6.1 Neurovascular Interventions Market 123
6.2 Improve Neurointerventional Device Design 123
6.3 Challenges in Treating Complex Intracranial Aneurysms and Arteriovenous Malformations 125
6.3.1 Intracranial Aneurysms 125
6.3.2 Intracranial Arteriovenous Malformations 126
6.4 Target Challenging Patient Populations 127
6.5 Optimize Care for Acute Ischemic Stroke Patients 127
6.6 Development of Drug-Eluting Devices 129
6.7 Emerging Markets 129
7 Market Drivers and Barriers 131
7.1 Market Drivers 131
7.1.1 Rising Prevalence of Disease 132
7.1.2 Improved Clinical Outcomes with Endovascular Coiling 133
7.1.3 Remodeling Techniques with Stent and Balloon-Assisted Coiling 134
7.1.4 Viable Therapeutic Option for Challenging/Complex Intracranial Aneurysms 136
7.1.5 Alternative Non-Coiling Embolization Devices for Aneurysm Treatment 137
7.1.6 Endovascular Embolization of Intracranial Arteriovenous Malformations 138
7.1.7 Imaging Assessment for Intracranial Arteriovenous Malformation Treatment 139
7.1.8 Stenting for Carotid Atherosclerotic Disease 139
7.1.9 Low-Profile Stent Systems 140
7.1.10 Improved Recanalization Rates with Mechanical Thrombectomy Devices 141
7.1.11 Cost Savings 143
7.1.12 Availability of Long-Term and Cost-Effective Data 143
7.2 Market Barriers 144
7.2.1 Complications of Neurointerventional Procedures and Devices 144
7.2.2 Lack of Clinical Data 150
7.2.3 High Cost of Treatment 150
7.2.4 Lack of Reimbursement 152
7.2.5 Lack of Superiority of Bioactive/Coated Coils 153
7.2.6 Alternative Technologies for Stroke Therapy 154
7.2.7 Regulatory Challenges: US Food and Drug Administration and European Conformity Mark 154
7.2.8 Healthcare Cost-Cutting and Reimbursement 155
7.2.9 Availability of Venture Capital 156
7.2.10 Medical Device Excise Tax 157
8 Competitive Assessment 158
8.1 Overview 158
8.2 Global Market Share 158
8.3 Marketed Products 159
8.3.1 Aachen Resonance 159
8.3.2 Abbott Vascular 161
8.3.3 Acandis 163
8.3.4 B. Braun 166
8.3.5 BALT Extrusion 167
8.3.6 Blockade Medical 172
8.3.7 Boston Scientific Corporation 173
8.3.8 Contego Medical 175
8.3.9 Cook Medical 175
8.3.10 Covidien 176
8.3.11 Gardia Medical 183
8.3.12 Gore Medical 184
8.3.13 InspireMD 186
8.3.14 ITGI Medical 187
8.3.15 Johnson & Johnson 188
8.3.16 Medikit 194
8.3.17 Medtronic 196
8.3.18 Merlin MD 199
8.3.19 MicroPort Scientific Corporation 200
8.3.20 Minvasys 202
8.3.21 Neuravi 203
8.3.22 Optimed 204
8.3.23 Penumbra 206
8.3.24 Phenox GmbH 209
8.3.25 Reverse Medical 211
8.3.26 Sequent Medical 213
8.3.27 Stryker Neurovascular Intervention 215
8.3.28 Terumo Corporation 222
8.3.29 Valor Medical 230
9 Pipeline Assessment 232
9.1 Overview 232
9.2 Pipeline by Stage of Development 232
9.3 Product Profiles 234
9.3.1 Aneurysm Occlusion Saddle 234
9.3.2 Ballstent Microcatheter 235
9.3.3 Blood Clot Removing Device 235
9.3.4 EKOS’ EkoSonic Small Vessel Endovascular System 236
9.3.5 Flow-Diverting Thin-Film Nitinol Covered Stent 236
9.3.6 Ischemic Stroke System 237
9.3.7 Janjua Aneurysm Net 238
9.3.8 Multilayer Aneurysm Repair System 238
9.3.9 NAVIMAX 239
9.3.10 Palmaz Scientific Stents 240
9.3.11 Silk Road System 241
9.3.12 Transcranial Thrombectomy Catheter 242
10 Clinical Trial Analysis 243
10.1 Overview 243
10.2 Clinical Trials to Watch 244
10.2.1 Embolization 244
10.2.2 Flow Diversion 246
10.2.3 Revascularization 249
10.2.4 Mechanical Thrombectomy 250
11 Current and Future Players 253
11.1 Overview 253
11.2 Trends in Corporate Strategy 253
11.3 Company Profiles 255
11.3.1 BALT Extrusion 255
11.3.2 Covidien 258
11.3.3 Johnson & Johnson 261
11.3.4 Penumbra 266
11.3.5 Stryker Corporation 269
11.3.6 Terumo Corporation 271
11.3.7 Abbott Vascular 275
11.3.8 Boston Scientific Corporation 277
11.3.9 Cook Medical 279
11.3.10 Gore Medical 281
11.3.11 Medtronic 283
11.3.12 Aachen Resonance 285
11.3.13 Acandis 287
11.3.14 B. Braun 290
11.3.15 Blockade Medical 291
11.3.16 Contego Medical 293
11.3.17 Gardia Medical 294
11.3.18 InspireMD 296
11.3.19 ITGI Medical 298
11.3.20 Medikit 299
11.3.21 Merlin MD 300
11.3.22 MicroPort Scientific Corporation 302
11.3.23 Minvasys 303
11.3.24 Neuravi 305
11.3.25 Optimed 306
11.3.26 Phenox GmBH 308
11.3.27 Reverse Medical 309
11.3.28 Sequent Medical 311
11.3.29 Valor Medical 312
11.3.30 Other Companies 315
12 Market Outlooks 317
12.1 By Market Segment 317
12.1.1 Embolization Device Market 319
12.1.2 Revascularization Device Market 323
12.1.3 Mechanical Thrombectomy Device Market 326
12.1.4 Access/Support Device Market 329
12.2 By Geography 331
12.2.1 Global Overview 331
12.2.2 United States 332
12.2.3 The Five European Union Markets 339
12.2.4 The Asia-Pacific Region 367
12.2.5 South America 386
13 Appendix 393
13.1 Bibliography 393
13.2 Abbreviations 417
13.3 Report Methodology 423
13.3.1 Overview 423
13.3.2 Coverage 423
13.3.3 Secondary Research 423
13.4 Physicians and Specialists Included in this Study 424
13.4.1 Vivek Gupta, MD 424
13.4.2 Zsolt Kulscár, MD, PhD 424
13.4.3 Salvatore Mangiafico, MD 424
13.4.4 Thanh Nguyen, MD, FRCPc 424
13.4.5 Eduardo Wajnberg, MD 425
13.4.6 Phil White, MD 425
13.4.7 Osama O Zaidat, MD, MS, FAAN, FAHA 425
13.5 Primary Research 425
13.5.1 Primary Research – Key Opinion Leader Interviews 425
13.5.2 Expert Panel Validation 426
13.6 Forecasting Methodology 427
13.7 About the Authors 429
13.7.1 Analysts 429
13.7.2 Global Head of Healthcare 430
13.8 About MediPoint 431
13.9 About GlobalData 431
13.10 Disclaimer 431
【レポート販売概要】
■ タイトル：世界における神経血管インターベンション市場■ 英文：MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts
■ 発行日：2014年4月2日
■ 調査会社：GlobalData
■ 商品コード：GDME0194MAR
■ 調査対象地域：グローバル
- 2014年戦略提言：Shigella診断検査市場The report presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Shigella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comme …
- 防水システムの東南アジア市場：既成膜（変性瀝青、PVC、TPO、EPDM）、塗膜（エラストマー、セメント混合、歴青質）、統合システム（ポアブロッキング剤、結晶防水剤）、防水化学品 （瀝青、エラストマー、PVC、TPO、EPDM、コンクリート）The market size of Southeast Asia waterproofing systems market is estimated to reach USD 5.35 Billion by 2021, at a CAGR of 14.52% during the forecast period. The rising demand for waterproofing is backed by the growing building & construction industry in the region, especially in the developing countries, such as Indonesia, Malaysia, Thailand, Singapore, and Vietnam. Rapid growth in the construct …
- ブリスター包装の世界市場予測（～2022年）“Growth in demand from the healthcare industry to drive the market for blister packaging” The global market for blister packaging is projected to grow from USD 18.65 billion in 2016 to reach USD 28.38 billion by 2022, at an estimated CAGR of 7.2%. The blister packaging market is driven by factors such as growth in demand for sustainable packaging, increase in demand for flexible packaging, cost-ef …
- グローバル石油・ガス産業サーベイ（2013-2014）：市場動向、購買戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global oil and gas industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global oil and gas industry. The report includes key topics such as global oil and gas industry buyer expenditure and procurement behavio …
- Typhoid Fever：グローバル臨床試験レビューH2, 2013Typhoid Fever Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, H2, 2013" provides data on the Typhoid Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Typhoid Fever. It includes an overview of the trial numbers and their recruitment status as per the …
- 世界の潜水艦市場（2014-2024）：地域別分析Synopsis This report offers detailed analysis of the global Submarine market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Submarine market. Summary "The Global Submarine Market 2014-2024 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an anal …
- 商業用空港照明の世界市場2019-2023About this market Construction of new airports and modernization of existing airport infrastructure will be key factor driving the growth of the global commercial airport lighting market. Many countries are investing in new and improved infrastructure to manage the growing air traffic and maintain high level of service. Countries are focusing on renovating their airport infrastructure to modernize …
- ドローン識別システムの世界市場2018-2022About Drone Identification Systems Drone identification systems include anti-drone systems used by end-users to detect, classify, and mitigate unmanned aerial vehicles (UAVs) that are a threat to them. Technavio’s analysts forecast the global drone identification systems market to grow at a CAGR of 24.25% during the period 2018-2022. Covered in this report The report covers the present scenario an …
- セラミックフィルターの世界市場分析：製品別（水フィルター、エアーフィルター）、用途別（住宅、商業、工業、高温ガスろ過、油/水ろ過、バイオろ過）、セグメント予測 -2022GlobalCeramic Filters Market is expected to reach USD 2,139.4 million by 2022, according to a new study by Grand View Research, Inc. Favorable regulations for both water and air filtration across key regions is expected remain a key driving factor for global ceramic filters market. Superior quality and performance over its polymeric counterpart is also expected to have a positive influence on the …
- Oblean（肥満治療薬）：市場予測及び分析（～2022）Oblean (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molec …
- ボツリヌス毒素の世界市場2017-2021ABSTRACTAbout Botulinum Toxin Botulinum toxin is a chemical substance, which is used as a drug to regulate the release of acetylcholine, the chemical that regulates the neuron flow in the nervous system to activate the muscles. To be used as a drug, botulinum toxin must be isolated, purified, and stabilized. This substance finds its place largely as one of the most sought-after muscle relaxants in …
- Zigbee対応デバイスの世界市場：STB、スマートメーター、リモコン、コネクテッド電球、スマート・サーモスタットAbout Zigbee enabled Devices ZigBee is a wireless and open global standard with added benefits such as low-cost, low-power wireless machine-to-machine (M2M) networks. The ZigBee standard is the only wireless technology that enables device-to-device communication and functions on Institute of Electrical and Electronics Engineers (IEEE) 802.15.4 physical radio specification in unsanctioned bands inc …
- タッチスクリーンコントローラの世界市場予測（～2022年）The touchscreen controller market was valued at USD 3.68 Billion in 2015 and is expected to reach USD 9.11 Billion by 2022, at a CAGR of 15.2% between 2016 and 2022. The growth of this market is propelled by the increasing use of touchscreen in automobiles. With the introduction of touch panels, a market potential for the touch controllers has also been established. Therefore, the demand for touch …
- クロスフロー膜の世界市場2017-2021About Cross Flow MembraneCross-flow filtration, also known as tangential flow filtration, is a type of filtration in which the feed flows or travels parallel to the membrane surface rather than traveling perpendicular to the surface or through the membrane as in the case of conventional filtration processes. Technavio’s analysts forecast the global cross flow membrane market to grow at a CAGR of 6 …
- 自動車産業向けオートメーション製品の世界市場：PLM、センサー、DCS、PLC、MES、SCADAThe automotive industry has great scope for automation solutions because the dynamic nature of consumer demand requires improved safety standards in vehicles and the use of advanced technologies such as connected and automated cars. The growth of automation solutions in the automotive industry will be driven by the expansion of plant capacity in countries such as the US, China, Germany, Italy, and …
